Engineered exosomes in emerging cell-free therapy DOI Creative Commons

Chaohua Si,

Jianen Gao, Xu Ma

et al.

Frontiers in Oncology, Journal Year: 2024, Volume and Issue: 14

Published: March 26, 2024

The discovery and use of exosomes ushered in a new era cell-free therapy. Exosomes are subgroup extracellular vesicles that show great potential disease treatment. Engineered exosomes. with their improved functions have attracted intense interests application translational medicine research. However, the technology engineering still faces many challenges which been limitation for clinical application. This review summarizes current status research on engineered difficulties encountered recent years, view to providing approaches ideas future exosome modification drug development.

Language: Английский

Profile of crosstalk between glucose and lipid metabolic disturbance and diabetic cardiomyopathy: Inflammation and oxidative stress DOI Creative Commons
Mengyuan Chen, Xiangfei Meng,

Yu-Peng Han

et al.

Frontiers in Endocrinology, Journal Year: 2022, Volume and Issue: 13

Published: Sept. 15, 2022

In recent years, the risk, such as hypertension, obesity and diabetes mellitus, of cardiovascular diseases has been increasing explosively with development living conditions expansion social psychological pressure. The disturbance glucose lipid metabolism contributes to both collapse myocardial structure cardiac dysfunction, which ultimately leads diabetic cardiomyopathy. pathogenesis cardiomyopathy is multifactorial, including inflammatory cascade activation, oxidative/nitrative stress, following impaired Ca2+ handling induced by insulin resistance/hyperinsulinemia, hyperglycemia, hyperlipidemia in diabetes. Some key alterations cellular signaling network, translocation CD36 sarcolemma, activation NLRP3 inflammasome, up-regulation AGE/RAGE system, disequilibrium micro-RNA, mediate oxidative stress/inflammation related remodeling ventricular dysfunction context metabolic disturbance. Here, we summarized detailed network abnormality facilitates

Language: Английский

Citations

31

Berberine blocks inflammasome activation and alleviates diabetic cardiomyopathy via the miR‑18a‑3p/Gsdmd pathway DOI
Lin Yang,

Chunfeng Cheng,

Zhifang Li

et al.

International Journal of Molecular Medicine, Journal Year: 2023, Volume and Issue: 51(6)

Published: April 24, 2023

Diabetic cardiomyopathy (DCM) is a cardiovascular disease which has been reported as major cause of mortality worldwide for several years. Berberine (BBR) natural compound extracted from Chinese herb, with clinically anti‑DCM effect; however, its molecular mechanisms have not yet fully elucidated. The present study indicated that BBR markedly alleviated DCM by inhibiting IL‑1β secretion and the expression gasdermin D (Gsdmd) at post‑transcriptional level. Considering importance microRNAs (miRNAs/miRs) in regulation process specific genes, ability to upregulate levels miR‑18a‑3p activating promoter (‑1,000/‑500) was examined. Notably, targeted Gsdmd abated pyroptosis high glucose‑treated H9C2 cells. Moreover, overexpression inhibited improved biomarkers cardiac function rat model DCM. On whole, findings indicate alleviates miR‑18a‑3p‑mediated activation; thus, may be considered potential therapeutic agent treatment

Language: Английский

Citations

22

The Role of MicroRNA in the Pathogenesis of Diabetic Nephropathy DOI Open Access

Joanna Szostak,

Anna Gorący,

Damian Durys

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(7), P. 6214 - 6214

Published: March 25, 2023

Diabetic nephropathy is one of the most common and severe complications diabetes mellitus, affecting in every five patients suffering from diabetes. Despite extensive research, exact pathogenesis diabetic still unclear. Several factors pathways are known to be involved development disease, such as reactive oxygen species or activation renin–angiotensin–aldosterone system. The expression those proteins might extensively regulated by microRNA. Recent research suggests that patients, profile miRNA significantly changed. In this review, we focus on actions various clinical usage miRNAs biomarkers therapeutic targets.

Language: Английский

Citations

20

Global trends and performances in diabetic retinopathy studies: A bibliometric analysis DOI Creative Commons
Huan Xiao,

Jinfan Tang,

Feng Zhang

et al.

Frontiers in Public Health, Journal Year: 2023, Volume and Issue: 11

Published: April 13, 2023

The objective of this study is to conduct a comprehensive bibliometric analysis identify and evaluate global trends in diabetic retinopathy (DR) research visualize the focus frontiers field.Diabetic retinopathy-related publications from establishment Web Science (WOS) through 1 November 2022 were retrieved for qualitative quantitative analyses. This analyzed annual publication counts, prolific countries, institutions, journals, top 10 most cited literature. findings presented descriptive statistics. VOSviewer 1.6.17 was used exhibit keywords with high frequency national cooperation networks, while CiteSpace 5.5.R2 displayed timeline burst each term.A total 10,709 references analyzed, number continuously increased over investigated period. America had highest h-index citation frequency, contributing influence. China country, producing 3,168 articles. University London productivity. three productive journals America, Investigative Ophthalmology Visual publications. article Gulshan et al. (2016; co-citation 2,897) served as representative symbolic reference. main topics area incidence, pathogenesis, treatment, artificial intelligence (AI). Deep learning, models, biomarkers, optical coherence tomography angiography (OCTA) DR frontier hotspots.Bibliometric provided valuable insights into frontiers. Four key directions extracted extensive DR-related As incidence continues increase, prevention treatment have become pressing public health concern significant interest. In addition, development AI technologies telemedicine has emerged promising balancing doctors patients.

Language: Английский

Citations

20

Engineered exosomes in emerging cell-free therapy DOI Creative Commons

Chaohua Si,

Jianen Gao, Xu Ma

et al.

Frontiers in Oncology, Journal Year: 2024, Volume and Issue: 14

Published: March 26, 2024

The discovery and use of exosomes ushered in a new era cell-free therapy. Exosomes are subgroup extracellular vesicles that show great potential disease treatment. Engineered exosomes. with their improved functions have attracted intense interests application translational medicine research. However, the technology engineering still faces many challenges which been limitation for clinical application. This review summarizes current status research on engineered difficulties encountered recent years, view to providing approaches ideas future exosome modification drug development.

Language: Английский

Citations

8